• Je něco špatně v tomto záznamu ?

Epistatic effect of TLR3 and cGAS-STING-IKKε-TBK1-IFN signaling variants on colorectal cancer risk

C. Catalano, MI. da Silva Filho, C. Frank, S. Lu, K. Jiraskova, V. Vymetalkova, M. Levy, V. Liska, O. Vycital, A. Naccarati, L. Vodickova, K. Hemminki, P. Vodicka, ANR. Weber, A. Försti

. 2020 ; 9 (4) : 1473-1484. [pub] 20191223

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, pozorovací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21020762

Grantová podpora
NV15-27580A MZ0 CEP - Centrální evidence projektů

OBJECTIVE: The TLR3/cGAS-STING-IFN signaling has recently been reported to be disturbed in colorectal cancer due to deregulated expression of the genes involved. Our study aimed to investigate the influence of potential regulatory variants in these genes on the risk of sporadic colorectal cancer (CRC) in a Czech cohort of 1424 CRC patients and 1114 healthy controls. METHODS: The variants in the TLR3, CGAS, TMEM173, IKBKE, and TBK1 genes were selected using various online bioinformatic tools, such as UCSC browser, HaploReg, Regulome DB, Gtex Portal, SIFT, PolyPhen2, and miRNA prediction tools. RESULTS: Logistic regression analysis adjusted for age and sex detected a nominal association between CRC risk and three variants, CGAS rs72960018 (OR: 1.68, 95% CI: 1.11-2.53, P-value = .01), CGAS rs9352000 (OR: 2.02, 95% CI: 1.07-3.84, P-value = .03) and TMEM173 rs13153461 (OR: 1.53, 95% CI: 1.03-2.27, P-value = .03). Their cumulative effect revealed a threefold increased CRC risk in carriers of 5-6 risk alleles compared to those with 0-2 risk alleles. Epistatic interactions between these genes and the previously genotyped IFNAR1, IFNAR2, IFNA, IFNB, IFNK, IFNW, IRF3, and IRF7 genes, were computed to test their effect on CRC risk. Overall, we obtained nine pair-wise interactions within and between the CGAS, TMEM173, IKBKE, and TBK1 genes. Two of them remained statistically significant after Bonferroni correction. Additional 52 interactions were observed when IFN variants were added to the analysis. CONCLUSIONS: Our data suggest that epistatic interactions and a high number of risk alleles may play an important role in CRC carcinogenesis, offering novel biological understanding for the CRC management.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020762
003      
CZ-PrNML
005      
20210830102416.0
007      
ta
008      
210728s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/cam4.2804 $2 doi
035    __
$a (PubMed)31869529
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Catalano, Calogerina $u Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany $u Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
245    10
$a Epistatic effect of TLR3 and cGAS-STING-IKKε-TBK1-IFN signaling variants on colorectal cancer risk / $c C. Catalano, MI. da Silva Filho, C. Frank, S. Lu, K. Jiraskova, V. Vymetalkova, M. Levy, V. Liska, O. Vycital, A. Naccarati, L. Vodickova, K. Hemminki, P. Vodicka, ANR. Weber, A. Försti
520    9_
$a OBJECTIVE: The TLR3/cGAS-STING-IFN signaling has recently been reported to be disturbed in colorectal cancer due to deregulated expression of the genes involved. Our study aimed to investigate the influence of potential regulatory variants in these genes on the risk of sporadic colorectal cancer (CRC) in a Czech cohort of 1424 CRC patients and 1114 healthy controls. METHODS: The variants in the TLR3, CGAS, TMEM173, IKBKE, and TBK1 genes were selected using various online bioinformatic tools, such as UCSC browser, HaploReg, Regulome DB, Gtex Portal, SIFT, PolyPhen2, and miRNA prediction tools. RESULTS: Logistic regression analysis adjusted for age and sex detected a nominal association between CRC risk and three variants, CGAS rs72960018 (OR: 1.68, 95% CI: 1.11-2.53, P-value = .01), CGAS rs9352000 (OR: 2.02, 95% CI: 1.07-3.84, P-value = .03) and TMEM173 rs13153461 (OR: 1.53, 95% CI: 1.03-2.27, P-value = .03). Their cumulative effect revealed a threefold increased CRC risk in carriers of 5-6 risk alleles compared to those with 0-2 risk alleles. Epistatic interactions between these genes and the previously genotyped IFNAR1, IFNAR2, IFNA, IFNB, IFNK, IFNW, IRF3, and IRF7 genes, were computed to test their effect on CRC risk. Overall, we obtained nine pair-wise interactions within and between the CGAS, TMEM173, IKBKE, and TBK1 genes. Two of them remained statistically significant after Bonferroni correction. Additional 52 interactions were observed when IFN variants were added to the analysis. CONCLUSIONS: Our data suggest that epistatic interactions and a high number of risk alleles may play an important role in CRC carcinogenesis, offering novel biological understanding for the CRC management.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a karcinogeneze $x genetika $7 D063646
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a kohortové studie $7 D015331
650    _2
$a kolon $x diagnostické zobrazování $x patologie $7 D003106
650    _2
$a kolonoskopie $7 D003113
650    _2
$a kolorektální nádory $x diagnóza $x genetika $x patologie $7 D015179
650    _2
$a výpočetní biologie $7 D019295
650    12
$a genetická epistáze $7 D004843
650    _2
$a ženské pohlaví $7 D005260
650    12
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a genotypizační techniky $7 D060005
650    _2
$a zdraví dobrovolníci pro lékařské studie $7 D064368
650    _2
$a lidé $7 D006801
650    _2
$a kinasa I-kappa B $x genetika $7 D051550
650    _2
$a interferony $x genetika $7 D007372
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a membránové proteiny $x genetika $7 D008565
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nukleotidyltransferasy $x genetika $7 D009713
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a protein-serin-threoninkinasy $x genetika $7 D017346
650    _2
$a rektum $x diagnostické zobrazování $x patologie $7 D012007
650    _2
$a signální transdukce $x genetika $7 D015398
650    _2
$a toll-like receptor 3 $x genetika $7 D051196
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a da Silva Filho, Miguel Inacio $u Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
700    1_
$a Frank, Christoph $u Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
700    1_
$a Lu, Shun $u Sichuan Cancer Center, School of Medicine, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China
700    1_
$a Jiraskova, Katerina $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, the Czech Academy of Sciences, Prague, Czech Republic $u 1st Medical Faculty, Institute of Biology and Medical Genetics, Charles University, Prague, Czech Republic
700    1_
$a Vymetalkova, Veronika $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, the Czech Academy of Sciences, Prague, Czech Republic $u 1st Medical Faculty, Institute of Biology and Medical Genetics, Charles University, Prague, Czech Republic $u Faculty of Medicine in Pilsen, Biomedical Center, Charles University Prague, Pilsen, Czech Republic
700    1_
$a Levy, Miroslav $u First Medical Faculty, Department of Surgery, Charles University and Thomayer Hospital, Prague, Czech Republic
700    1_
$a Liska, Vaclav $u Faculty of Medicine in Pilsen, Biomedical Center, Charles University Prague, Pilsen, Czech Republic $u Department of Surgery, Teaching Hospital and Medical School of Charles University, Pilsen, Czech Republic
700    1_
$a Vycital, Ondrej $u Faculty of Medicine in Pilsen, Biomedical Center, Charles University Prague, Pilsen, Czech Republic $u Department of Surgery, Teaching Hospital and Medical School of Charles University, Pilsen, Czech Republic
700    1_
$a Naccarati, Alessio $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, the Czech Academy of Sciences, Prague, Czech Republic $u Molecular and Genetic Epidemiology, Italian Institute for Genomic Medicine (IIGM), Turin, Italy
700    1_
$a Vodickova, Ludmila $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, the Czech Academy of Sciences, Prague, Czech Republic $u 1st Medical Faculty, Institute of Biology and Medical Genetics, Charles University, Prague, Czech Republic $u Faculty of Medicine in Pilsen, Biomedical Center, Charles University Prague, Pilsen, Czech Republic
700    1_
$a Hemminki, Kari $u Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany $u Center for Primary Health Care Research, Clinical Research Center, Lund University, Malmö, Sweden
700    1_
$a Vodicka, Pavel $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, the Czech Academy of Sciences, Prague, Czech Republic $u 1st Medical Faculty, Institute of Biology and Medical Genetics, Charles University, Prague, Czech Republic $u Faculty of Medicine in Pilsen, Biomedical Center, Charles University Prague, Pilsen, Czech Republic
700    1_
$a Weber, Alexander N R $u Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Baden-Württemberg, Tübingen, Germany
700    1_
$a Försti, Asta $u Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany $u Center for Primary Health Care Research, Clinical Research Center, Lund University, Malmö, Sweden $u Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany
773    0_
$w MED00181704 $t Cancer medicine $x 2045-7634 $g Roč. 9, č. 4 (2020), s. 1473-1484
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31869529 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830102416 $b ABA008
999    __
$a ok $b bmc $g 1691355 $s 1141208
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 9 $c 4 $d 1473-1484 $e 20191223 $i 2045-7634 $m Cancer medicine $n Cancer Med $x MED00181704
GRA    __
$a NV15-27580A $p MZ0
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Možnosti archivace